Branded Legacy Advances Intranasal Drug Delivery Platform with Unitary Device Mold Development

Branded Legacy, Inc. (OTC: BLEG) has initiated the engineering and development phase for a unitary device mold supporting its proprietary air-driven intranasal drug delivery platform. This advancement represents a critical milestone in the company's efforts to scale production of single-use devices designed for rapid and reliable therapeutic delivery, particularly for its flagship inhaled naloxone program. The development builds upon a provisional patent filing from September 2025 and the recent establishment of a GMP-compliant manufacturing facility in Vancouver.

This strategic progression strengthens Branded Legacy's capacity to provide affordable, high-quality pharmaceutical solutions aimed at combating the ongoing opioid crisis through innovative harm reduction technologies. Through its subsidiary BioLegacy Evaluative Group Inc., the company is focusing on creating scalable manufacturing processes for its air-driven delivery system. The technology is positioned to offer significant advantages in emergency situations where rapid administration of life-saving medications like naloxone is crucial for reversing opioid overdoses.

Branded Legacy maintains strategic research collaborations with leading academic institutions including McMaster University and Stanford University, supporting the development of transformative solutions in addiction treatment and harm reduction. The company's comprehensive approach combines advanced research capabilities with state-of-the-art manufacturing infrastructure to address critical public health challenges. The engineering phase for the unitary device mold represents a tangible step toward commercial production of the intranasal delivery platform.

This development aligns with the company's broader mission of creating accessible pharmaceutical solutions that can be rapidly deployed in emergency situations where traditional delivery methods may be less effective or practical. For additional information about Branded Legacy's initiatives and corporate developments, interested parties can visit the company's official website at https://BrandedLegacy.com. The company continues to leverage its specialized expertise and manufacturing capabilities to develop innovative solutions for addressing substance use disorders and related public health challenges.